Literature DB >> 8183117

Experimental study of the osteogenic capacity of periosteal allografts: a preliminary report.

J Y Liu1, D Wang, H H Cheng.   

Abstract

A total of 16 rabbits were used in this investigation. Beijing long-eared white rabbits served as donors and immunologically incompatible Chinchilla rabbits as recipients. Periosteal flaps were stripped from the femurs of 8 donor rabbits and implanted into the muscles of both thighs of 8 recipients. Revascularization of the grafts was done only on the left side. Immunosuppressants were administered orally beginning the day of surgery. The animals were observed for 1-4 months. A series of radiography, histomorphology, fluorochrome labelling, and electron microscopic examinations were performed. The results demonstrated that all of the revascularized periosteal allografts had new bone formation (8/8), while the nonrevascularized periosteal allografts had none (0/8). The difference in the rate of new bone formation between the two groups was statistically significant.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8183117     DOI: 10.1002/micr.1920150202

Source DB:  PubMed          Journal:  Microsurgery        ISSN: 0738-1085            Impact factor:   2.425


  3 in total

1.  The Vascularized Medial Femoral Corticoperiosteal Flap for Reconstruction of Bony Defects within the Upper and Lower Extremities.

Authors:  Karim Bakri; Alexander Y Shin; Steven L Moran
Journal:  Semin Plast Surg       Date:  2008-08       Impact factor: 2.314

Review 2.  Multiscale mechanobiology of de novo bone generation, remodeling and adaptation of autograft in a common ovine femur model.

Authors:  Melissa L Knothe Tate; Scott Dolejs; Sarah H McBride; R Matthew Miller; Ulf R Knothe
Journal:  J Mech Behav Biomed Mater       Date:  2011-03-16

Review 3.  Progress of Periosteal Osteogenesis: The Prospect of In Vivo Bioreactor.

Authors:  Xiaoxue Chen; Baofu Yu; Zi Wang; Qingfeng Li; Chuanchang Dai; Jiao Wei
Journal:  Orthop Surg       Date:  2022-07-06       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.